Research Paper Volume 13, Issue 20 pp 23739—23756
Loganin substantially ameliorates molecular deficits, pathologies and cognitive impairment in a mouse model of Alzheimer’s disease
Figure 7. Validation of key proteins involving in neuroprotective effects of loganin. (A–D) The relative expression of energy metabolism, synaptic proteins, and inflammatory response related proteins in WT mice and 3xTg-AD mice with or without loganin treatment. Data were expressed as mean ± SEM, *p < 0.05, n =3 for each group.